Combination therapy in type 2 diabetes: Repaglinide/metformin vs glyburide/metformin

被引：0
|
作者：
Jinagouda, S
Schwartz, S
Huffman, D
Weinstein, R
Davidson, J
Huang, WC
Reinhardt, R
机构：
来源：
DIABETES | 2001年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A439 / A439
页数：1
相关论文
共 50 条
  • [1] Repaglinide in combination therapy with metformin in Type 2 diabetes
    Moses, R
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1999, 107 : S136 - S139
  • [2] Combination therapy for patients with Type 2 diabetes: repaglinide in combination with metformin
    Moses, Robert G.
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (03) : 331 - 342
  • [3] Pharmacodynamics of Glyburide, Metformin, and Glyburide/Metformin Combination Therapy in the Treatment of Gestational Diabetes Mellitus
    Shuster, Diana L.
    Shireman, Laura M.
    Ma, Xiaosu
    Shen, Danny D.
    Nichols, Shannon K. Flood
    Ahmed, Mahmoud S.
    Clark, Shannon
    Caritis, Steve
    Venkataramanan, Raman
    Haas, David M.
    Quinney, Sara K.
    Haneline, Laura S.
    Tita, Alan T.
    Manuck, Tracy A.
    Thummel, Kenneth E.
    Brown, Linda Morris
    Ren, Zhaoxia
    Brown, Zane
    Easterling, Thomas R.
    Hebert, Mary F.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (06) : 1362 - 1372
  • [4] Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes
    Raskin, P.
    [J]. DIABETES OBESITY & METABOLISM, 2008, 10 (12): : 1167 - 1177
  • [5] Fixed combination of repaglinide and metformin in the management of type 2 diabetes
    Moses, Robert
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2009, 2 : 101 - 109
  • [6] Metformin/Repaglinide (PrandiMet) for Type 2 Diabetes
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2009, 51 (1313): : 41 - 43
  • [7] Glyburide/metformin (Glucovance) for type 2 diabetes
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2000, 42 (1092): : 105 - 106
  • [8] Alogliptin plus metformin combination therapy vs alogliptin or metformin monotherapy for type 2 diabetes mellitus
    Pratley, R.
    Wilson, C.
    Fleck, P.
    [J]. DIABETOLOGIA, 2012, 55 : S347 - S348
  • [9] Comparison of healthcare costs for repaglinide, metformin, repaglinide/metformin, and glyburide/metformin within a managed care organization
    Stockl, K
    Vanderplas, A
    Nicklasson, L
    [J]. VALUE IN HEALTH, 2003, 6 (03) : 335 - 335
  • [10] Beneficial effects of a glyburide/metformin combination preparation in Type 2 diabetes mellitus
    Bokhari, SU
    Gopal, UM
    Duckworth, WC
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 325 (02): : 66 - 69
12345